Cargando…
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
Our previous studies have implicated the Wnt antagonist, sFRP1, as a tumour suppressor gene in advanced colorectal cancer. In this study, we set out to investigate the relationship between sFRP1 expression and large bowel adenomas, a precursor of colorectal cancer. The induction of β-catenin/TCF med...
Autores principales: | Caldwell, G M, Jones, C E, Taniere, P, Warrack, R, Soon, Y, Matthews, G M, Morton, D G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361362/ https://www.ncbi.nlm.nih.gov/pubmed/16523202 http://dx.doi.org/10.1038/sj.bjc.6602967 |
Ejemplares similares
-
Reorganisation of Wnt-response pathways in colorectal tumorigenesis
por: Caldwell, G M, et al.
Publicado: (2008) -
Wnt signalling in adenomas of familial adenomatous polyposis patients
por: Caldwell, G M, et al.
Publicado: (2010) -
The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma
por: Kang, Pengcheng, et al.
Publicado: (2014) -
Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
por: Bhuvanalakshmi, Gurubharathi, et al.
Publicado: (2018) -
Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2
por: Bao, Haili, et al.
Publicado: (2020)